Brii Biosciences Limited (BRIBF)
OTCMKTS · Delayed Price · Currency is USD
0.2600
-0.0072 (-2.69%)
At close: May 5, 2025

Brii Biosciences Statistics

Total Valuation

BRIBF has a market cap or net worth of 154.85 million. The enterprise value is -162.80 million.

Market Cap 154.85M
Enterprise Value -162.80M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date Aug 19, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 719.26M
Shares Outstanding n/a
Shares Change (YoY) +0.30%
Shares Change (QoQ) +0.15%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 521.34M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 22.63
PB Ratio 0.43
P/TBV Ratio 0.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 2.34
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 3.16

Financial Position

The company has a current ratio of 31.18, with a Debt / Equity ratio of 0.01.

Current Ratio 31.18
Quick Ratio 29.97
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.07
Interest Coverage -170.69

Financial Efficiency

Return on equity (ROE) is -18.05% and return on invested capital (ROIC) is -8.84%.

Return on Equity (ROE) -18.05%
Return on Assets (ROA) -8.55%
Return on Invested Capital (ROIC) -8.84%
Return on Capital Employed (ROCE) -15.36%
Revenue Per Employee 69,810
Profits Per Employee -710,406
Employee Count 98
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.09% in the last 52 weeks. The beta is 1.48, so BRIBF's price volatility has been higher than the market average.

Beta (5Y) 1.48
52-Week Price Change +13.09%
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 30.05
Average Volume (20 Days) 28,473

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BRIBF had revenue of 6.84 million and -69.62 million in losses. Loss per share was -0.10.

Revenue 6.84M
Gross Profit 6.84M
Operating Income -55.33M
Pretax Income -70.20M
Net Income -69.62M
EBITDA -55.02M
EBIT -55.33M
Loss Per Share -0.10
Full Income Statement

Balance Sheet

The company has 317.89 million in cash and 3.84 million in debt, giving a net cash position of 314.05 million.

Cash & Cash Equivalents 317.89M
Total Debt 3.84M
Net Cash 314.05M
Net Cash Per Share n/a
Equity (Book Value) 357.04M
Book Value Per Share 0.50
Working Capital 320.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.09 million and capital expenditures -442,246, giving a free cash flow of -51.53 million.

Operating Cash Flow -51.09M
Capital Expenditures -442,246
Free Cash Flow -51.53M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -808.74%
Pretax Margin -1,026.08%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BRIBF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.30%
Shareholder Yield n/a
Earnings Yield -44.96%
FCF Yield -33.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BRIBF has an Altman Z-Score of 1.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.64
Piotroski F-Score 2